Loading...
Presenters at the 2022 San Antonio Breast Cancer Symposium (SABCS; December 6–10) reported the latest findings in breast cancer research. NEJM Group was on hand to cover the meeting. Here, NEJM Journal Watch Oncology and Hematology reports on some of the key studies, with clinical perspective provided by Editor-in-Chief Dr. William J. Gradishar and guest author Dr. Erika Hamilton. Dr. Hamilton is Director of Breast Cancer Research for Sarah Cannon Research Institute at Tennessee Oncology, Nashville.
Abstracts are available on the SABCS site; account registration is required to access all abstracts.
In second-line treatment of patients with hum…